MedTrace Logo

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

NCT05809128 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-03-25

No results posted yet for this study

Summary

Prospective observational study for onco-immunologic characterization and by bioimaging of breast neoplastic tissue of patients operated for breast cancer

Conditions

  • Breast Cancer Patients

Interventions

OTHER

surgery for breast cancer and imaging test evaluations

At the time of surgery, having completed the evaluation extemporaneous of the surgical piece, tissue samples will be collected to be stored from the material exceeding the completion of the patients' diagnosis. In addition, paramenters that can be extracted from radiodiagnostic images will be evaluated

Sponsors & Collaborators

  • IRCCS SYNLAB SDN

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-29
Primary Completion
2023-01-31
Completion
2025-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05809128 on ClinicalTrials.gov